CAMBRIDGE, Mass., April 27, 2016 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that management will be participating at the following investor conferences:
- Deutsche Bank 41st Health Care Conference, Boston, May 5th at 11:20 a.m. ET
- Bank of America Merrill Lynch Health Care Conference, Las Vegas, May 10th at 1:40 p.m. PT
- UBS Global Healthcare Conference, New York, May 23rd at 11:30a.m. ET
A live webcast of these presentations will be accessible on the Investors/Media section of Infinity’s website at www.infi.com, and will be available for 30 days following each event.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative biopharmaceutical company dedicated to discovering, developing and delivering best-in-class medicines to people with difficult-to-treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. For more information on Infinity, please refer to the company’s website at www.infi.com.
Contact:
Christi Waarich
Senior Manager, Investor Relations
617-453-1363 or christi.waarich@infi.com
Logo - http://photos.prnewswire.com/prnh/20150916/267365LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/infinity-to-participate-in-three-may-investor-conferences-300257999.html
SOURCE Infinity Pharmaceuticals, Inc.
